Highlights
- Sales over the Year and quarter: The company’s sales declined by -91.87 % over the year, decrease in net sales/revenue by -94 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 0 %. Marginal decrease of -20% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for Sarda Proteins Ltd. Profit dropped by -150 % Year to Year, Sarda Proteins Ltd’s profitability increased by 185.71 % in this quarter.
- EPS over the Year and quarter: EPS declined by -152.17 % Year to Year. EPS increased by 200 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0.738 Cr | Rs. 1 Cr | Rs. 0.06 Cr | -94 % | -91.87 % |
| Expenses | Rs. 0.77 Cr | Rs. 1.04 Cr | Rs. 0.08 Cr | -92.31 % | -89.61 % |
| Operating Profit | Rs. -0.03 Cr | Rs. -0.04 Cr | Rs. -0.02 Cr | + 50 % | + 33.33 % |
| OPM % | -4.07 % | -4 % | -33.33 % | -29.33 % | -29.26 % |
| Other Income | Rs. 0.04 Cr | Rs. 0.05 Cr | Rs. 0.04 Cr | -20 % | + 0 % |
| Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Depreciation | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Profit before tax | Rs. 0.01 Cr | Rs. 0.01 Cr | Rs. 0.02 Cr | + 100 % | + 100 % |
| Tax % | 766.67 % | 0 % | 5 % | + 5 % | -761.67 % |
| Net Profit | Rs. -0.04 Cr | Rs. 0.01 Cr | Rs. 0.02 Cr | + 100 % | + 150 % |
| EPS in Rs | Rs. -0.23 | Rs. 0.04 | Rs. 0.12 | + 200 % | + 152.17 % |
Today, we’re looking at Sarda Proteins Ltd’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -91.87 %. However, it did see a marginal slip of -94 % from the previous quarter. Expenses decreased slightly by -92.31 % quarter-on-quarter, aligning with the annual decline of -89.61 %. Operating profit, while up 33.33 % compared to last year, faced a quarter-on-quarter increase of 50 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -29.26 %, but a shrinkage of -29.33 % sequentially. Other income fell by -20 % compared to the last quarter, despite an annual growth of 0 %. Profit before tax grew annually by 100 % but saw an increase from the preceding quarter by 100 %.
Tax expenses as a percentage of profits decreased slightly by -761.67 % compared to last year, with a more notable quarter-on-quarter increase of 5 %. Net profit rose by 150 % year-on-year but experienced a 100 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 152.17 % but a quarterly rise of 200 %. In summary, Sarda Proteins Ltd’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0.738 Cr | Rs. 1 Cr | Rs. 0.06 Cr | -94 % | -91.87 % |
| Expenses | Rs. 0.77 Cr | Rs. 1.04 Cr | Rs. 0.08 Cr | -92.31 % | -89.61 % |
| Operating Profit | Rs. -0.03 Cr | Rs. -0.04 Cr | Rs. -0.02 Cr | + 50 % | + 33.33 % |
| Net Profit | Rs. -0.04 Cr | Rs. 0.01 Cr | Rs. 0.02 Cr | + 100 % | + 150 % |
| EPS in Rs | Rs. -0.23 | Rs. 0.04 | Rs. 0.12 | + 200 % | + 152.17 % |
In reviewing Sarda Proteins Ltd’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -91.87 % year-on-year, although there was a slight dip of -94 % from the previous quarter. Expenses decreased by -89.61 % compared to the previous year, with a decrease of -92.31 % quarter-on-quarter. Operating Profit surged by 33.33 % annually, and saw a 50 % increase from the last quarter.
Net Profit showed yearly increase of 150 %, and experienced a 100 % increase from the previous quarter. Earnings Per Share (EPS) rose by 152.17 % annually, however rose by 200 % compared to the last quarter. In essence, while Sarda Proteins Ltd exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
